THE VALUE CHAIN. The new 2016 Uganda Clinical Guidelines and Essential Medicines and Health Supplies List. In this issue
|
|
- Buddy Stewart
- 5 years ago
- Views:
Transcription
1 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER THE VALUE CHAIN ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER Welcome to the 7th issue of the VALUE CHAIN, a publication of the Pharmacy Division. You will find news and information from activities and events being implemented by the Pharmacy Division and partners to improve medicines management in Uganda. For comments or to contribute to the next issue, please contact uhsc@uhsc.ug. In this issue New 2016 UCG and EMHSL The new 2016 Uganda Clinical Guidelines and Essential Medicines and Health Supplies List Improving safety through NDA s GDP Malaria test and treat has improved as a result of SPARS USAID zero tolerance to fraud Video as a training tool in supportive supervision New pediatric TB medicines formulations Shorter Multi-drug resistant TB Turning in the tide in medicines management Moving to evidence based decision making Does quality of supervision impact medicine management improvement in health facilities? Introducing Implanon NXT The Essential Medicines and Health Supplies List for Uganda 2016 and Uganda Clinical Guidelines Medicine is a fast evolving field: new diseases and treatments emerge and new priorities and strategies are developed at national and international level. Accordingly, the Ministry of Health (MoH) periodically updates the Uganda Clinical Guidelines (UCG) to provide health professionals in Uganda with current recommendations on how best to manage the most common health conditions in Uganda. The guidelines are distillation of scientific evidence, cost evaluation and practical considerations to help health workers achieve the best outcome for patients and the most cost-effective use of the limited resources available. Based on the UCG, the national Essential Medicine and Health Supplies List of Uganda (EMHSLU) is also updated to guide the selection and procurement of appropriate medicines and health supplies. The 2016 UCG and EMHSLU incorporates current recommendations on HIV, TB and Malaria treatment, integrated community case management for child health and non-communicable diseases, among other areas. In updating the manuals, the MoH Clinical Services Department obtained input from 32 specialists from different therapeutic areas. Their recommendations were discussed in a four-day meeting with 120 participants from academic institutions, MoH technical programs, the National Drugs Authority, World Health Organization, National Medical Stores, health facility staff from different levels of care, and some development partners. After a final round of consultation within the Ministry of Health programs and district health representatives, the 2016 UCG and EMHSLU is now being printed for distribution in the near future. For the first time, the manuals were designed based on suggestions from health workers on how to make the presentation and flow of information more user friendly and easy to consult. These important tools if used well, can contribute to the improvement of health care in Uganda.
2 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 2 Editorial Morries Seru, Assistant Commissioner, Pharmacy Division. Dear Reader, The Ministry of Health, with support from various implementing partners, is implementing the national Supervision Performance Assessment and Recognition strategy (SPARS) to improve medicines management in all 116 districts. Medicines Management Supervisors (MMS) have received intensive training, motorbikes, computers, annual motorbike repair, services, tires, and air time as well as remuneration to facilitate regular supervision visits to health facilities in their district. Birna Trap, Chief of Party, Uganda Health Supply Chain Program. SPARS has proven to be a very effective strategy in building capacity in medicines management. However, improvements in facility performance are directly linked to the will of the facility staff and the in-charge to make the changes needed but also how often and how thoroughly MMS conduct their supervisory visits. Last year, about 400 MMS made an average of only about one visit per month namely 15 SPARS facility visits/year, ranging from just 1-67 visits. The time between SPARS visits to a facility also varied greatly, from less than 1 month to 4.5 years. The varied performance translates into a high cost of SPARS implementation as fixed repairs and maintenance costs are the same regardless of the number or quality of visits conducted. To address this issue, the Ministry of Health, Pharmacy Department will rigorously monitor MMS performance and Dear Reader, Five years after being introduced, only 50% of higher level and 30% of lower level health facilities are routinely and correctly filing in the stock book (HMIS #083). Why is it important that all facilities use the stock book? When the stock book is used correctly: You will always know what items are in stock, which report to District Health Officers on the performance of each MMS. Subsequent facilitation and rewards will be based on performance of individual MMS. Poor performing MMS will no longer be supported. To further strengthen SPARS we have introduced, Peer Strategy. This strategy is implemented by MOH, Regional Pharmacists, Pharmacy focal persons on the Regional performance Monitoring team and District Health Officers. Peer strategy is aimed at validating SPARS and highlighting challenges that are not reported in SPARS to relevant authorities for action to be taken. We hope that these steps will encourage all District Health Officers to take charge of SPARS implementation so that health facilities receive the full benefits of this important program that has proved to make a huge difference when well implemented. ones are out of stock and for how many days. You can easily calculate the current average monthly consumption of each item. With the average monthly consumption, you will know how many days or months the stock available will last. You will be able to accurately prepare your next order and annual procurement. Together, let us make sure that 2017 is the year that 100% of health facilities correctly fill and use their stock books. You can make the difference if your facility is not yet using the stock book, begin today! A filled out sample stock book page.
3 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 3 Improving patient safety through NDA s good distribution practice guidelines By Brian Sekayombya A model warehousing arrangement. The public will soon benefit from the stronger quality assurance regulations being put in place by the National Drug Authority (NDA). Weak licensing standards have allowed pharmaceutical wholesalers in Uganda to operate without proper documentation systems, uncontrolled supply lines and poor storage and transportation conditions which can affect not only the safety and efficacy of pharmaceutical products, but also compromises patient treatment outcomes. In 2016, NDA finalized the development of Good Distribution Practice (GDP) guidelines based on World Health Organization standards to strengthen regulatory oversight over Uganda s pharmaceutical product distribution chain. The new guidelines require wholesalers to have well documented quality assurance processes and procedures to control their supply chain from source to end users in order to maintain a quality product. The improved traceability of products from the source of supply to the end user will enable NDA to implement product recalls when needed. The GDP guidelines also stipulate that only licensed wholesalers will only be able to sell to pharmacy retailers and retailers only buy from licensed wholesalers. In rolling-out the GDP guidelines, NDA conducted country wide consultative and training meetings with 299 wholesalers and distributors in the Ugandan market to jointly develop a road map for implementing by January 2017, the start of the annual licensing period. Wholesalers welcomed the stronger regulations. As one participant said, it is high time that normalcy returns to the private pharmaceutical sector. The onus is on NDA to ensure that GDP happens. NDA please take the lead. NDA and the wholesalers agreed that because of the costs involved in implementing all the standards and regulations, the GDP guidelines will be Malaria test and treat has improved as a result of SPARS By Jimmy Opoka and Denis Okidi Malaria remains the leading cause of morbidity in Uganda contributing to 43% of mortality in children under 5 years due to poor diagnosis and treatment. In 2010 just 20% of malaria cases were treated in accordance to standard treatment guidelines. As part of addressing this challenge, the Ministry of Health in 2011 adopted the multipronged Supervision, Performance Assessment and Recognition Strategy (SPARS) to improve health worker capacity in medicines management. Over the last five years, the SPARS intervention has positively impacted on appropriate treatment of single diagnosed malaria. Malaria testing has improved by 51% (p<0.001), appropriate treatment improved at all levels of care by 42% (p<0.001) and use of antibiotics in malaria treatment reduced by 63% (p<0.001). SPARS has proven effective in strengthening test and treatment in malaria cases at all health facility levels and with the new revised SPARS form, medicines management supervisors will now improve linking tests results to treatment. implemented in a phased approach over three years with all wholesalers being GDP-compliant by licensing year Wholesalers requested that NDA: Enforce compliance to GDP guidelines uniformly across all wholesalers Have further consultations before implementing the transportation standards Set-up a help desk at NDA to provide wholesalers with technical support in areas such as developing standard operating procedures and quality assurance manuals. As NDA our mission is to ensure access to quality, safe and efficacious human and veterinary medicines and other health care products through the regulation and control of their production, importation, distribution and sale. GDP fits very well into the mission of NDA and we shall ensure that GDP is implemented by all wholesalers in the country. ~Senior Inspector, NDA~
4 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 4 Zero tolerance to fraud in USAID-funded programs By Narine Sorayan USAID, the US government agency in charge of distributing tax dollars to foreign aid projects, believes that every dollar counts and has zero tolerance for fraud, corruption and waste. USAID spends millions of dollars in implementation, coordination and management of the Supervision Performance Assessment and Recognition Strategy (SPARS) by district health teams to strengthen capacity for medicines management through the Uganda Health Supply Chain program (UHSC). Implementation of SPARS is done by district-based Medicines Management Supervisors (MMS) who are supposed to demonstrate ethical conduct and a commitment to compliance at all times. However, a recent MMS supervision visit audit conducted by UHSC detected fraudulent practices by two MMS in two different districts: they reported supervisory visits to four facilities that had not actually taken place. This malpractice greatly undermines the huge investments directed to development and touches on the good work of the majority of the MMS. The MoH Pharmacy Department sent letters to the two District Health Officers to reiterate that MoH and USAID have a zero tolerance policy to fraud and such a breach of trust by MMS would jeopardize future USAID support to the SPARS program and the health sector in general. The District Health Officers were requested to take appropriate preventive and corrective actions to address the incidents of SPARS supervision fraud in those two districts. The MoH approach to the prevention, detection and remediation of fraud is based on the following principles: Fraud and corruption seriously impact achievement of the goals of the UHSC and other donorfunded programs MMS are held to the highest ethical standards in their conduct and work It is the responsibility of the MoH as a whole and each individual MMS to help deter and prevent fraud. USAID support to the MoH and district health authorities is meant for health sector interventions to benefit the population. Serious misconduct such as fraud and concerns about professional integrity can have negative ramifications for future aid work in the country. Video as a training tool in supportive supervision By Richard Odoi A discussion group acting out a typical feedback support supervision meeting by a medicines management supervisor. An innovative new training course in Uganda is using videography to help Medicine Management Supervisors (MMS) learn and practice skills in communication, motivational interviewing and behavior change so that they can be more effective in improving health worker practices. The use of video as a training tool has been shown to be effective in improving self-awareness through selfobservation and behavior change through constructive feedback from peers. In designing the course the Makerere University College of Health Sciences Pharmacy Department training team first underwent one week of training on videography. They then produced several video vignettes (5-8 minutes long) of MMS interacting with health workers in facilities to demonstrate the ideal supportive supervision behaviors and practices in different areas such as effective communication skills, behavior change and problem identification. After viewing each vignette, participants were asked to act out what they learned. Three or four groups of participants each made a video which was then critiqued in a plenary session. The topics most liked by participants were effective communication skills and behavior change. The whole course is very interactive, very focused and participants are really engaged, says Richard Odoi. In the beginning the weaknesses in participant skills were very apparent but as they went through the training modules their skills built up. By the end of the one week course, the improvements were noticeable. To reinforce what the MMS learned in the course, Regional Pharmacists who were also trained on videography will in 2017 videotape MMS during their regular facility visits so that they can see and critique their performance.
5 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 5 New pediatric TB medicines formulations By Victoria Nakiganda New pediatric TB medicine formulations are now available and being introduced in Uganda and other countries which will make it easier to achieve the optimum dosing for children. The new formulations, which are expected to arrive in Uganda in April 2017, will do away with the previous practice of crushing adult formulations which are unpalatable and make accurate dosing very difficult. The World Health Organization (WHO) revised the guidelines for drugsensitive TB treatment for children in 2010, recognizing that children need higher doses of the TB medicines than what they were receiving. There were, however, no companies producing products conforming to the new guidelines. In December 2015, TB Alliance, an international non-profit organization and its partners WHO and others with funding from UNITAID and USAID announced the global availability of quality-assured, affordable, childfriendly TB medicines in the correct internationally-recommended dosages to market. They are dispersible, palatable, simple to administer and affordable. The availability of correctly dosed medications will improve treatment for children everywhere. This is an important step toward ending the neglect that has characterized the care of children with TB for far too long, said TB Alliance President Dr. Mel Spigelman. The new medicines are fixed dose combinations (FDCs) that contain the proper doses for children of multiple drugs. They are available in a fruit flavor that is palatable for children. These medicines are not new treatments, but are improved formulations that are simple for providers and parents to administer and easy for children to take. No crushing or breaking is needed. They are made to dissolve in water in just a few seconds. For more information about the products, visit tballiance.org/child-friendlymedicines. TB Alliance is working with WHO, UNICEF, Management Sciences for Health and other organizations to encourage uptake in countries with Shorter Multi-drug resistant TB regimen high TB burdens. In Uganda, the MSH project Uganda Health Supply Chain is supporting the National TB and Leprosy Programme to ensure a smooth introduction of the new medicines with clear communication messages and job aids for health workers. One important message is that the current pediatric formulations (RHZ 60/30/150mg, RH 60/30mg, RHZ 75/50/150mg and RH 75/50mg) are still effective using the 2010 dosing guidelines and should not be wasted. Dosing chart of the new pediatric TB formulations Weight bands Intensive Phase RHZ (75/50/150mg) E (100mg) 4-7 kg kg kg kg kg and above Use adult dosages and formulations Continuation Phase Features of the shorter Multi drug resistant TB regimen RH (75/50mg) National TB & Leprosy programme Standard Operating procedures on how to use the new pediatric TB formulations. By Dr Frank Mugabe In May 2016, the World Health Organization updated its treatment guidelines for multidrug-resistant tuberculosis (MDR-TB) and included a recommendation on the use of the shorter MDR-TB regimen under specific conditions. Multi-drug resistant (MDR) tuberculosis is a growing public health crisis in many countries. In Uganda, 252 patients are currently being treated for MDR TB, a relatively small number. But the National TB and Leprosy Program (NTLP) estimates this will increase to more than 1,000 patients in the near future. The long treatment period 20 months presents a major burden on patients to adhere to the daily regimen, including the side effects of the medicines. The new WHO guidelines shortens the treatment period to less than 12 months for patients meeting certain criteria. The NTLP will begin using the shorter MDR TB regimen sometime in late The shorter regimen is already in use in 14 countries in Africa and Asia with promising results. The shorter regimen is expected to benefit majority of MDR-TB patients. However, the World Health Organization cautions that there are serious risks for worsening resistance if the regimen is used inappropriately for example in XDR-TB patients. Standardized shorter MDR-TB regimen with seven drugs and a treatment duration of 9-12 months Indicated conditionally in MDR-TB or rifampicin resistant-tb, regardless of patient age or HIV status Monitoring for effectiveness, harms and relapse will be needed, with patient-centered care and social support to enable adherence Programmatic use is feasible in most settings worldwide Lowered costs (<US$1,000 in drug costs/patient) and reduced patient loss expected Exclusion criteria: 2nd line drug resistance, extrapulmonary disease and pregnancy Exclusion criteria: 2nd line drug resistance, extrapulmonary disease and pregnancy World Health Organization May
6 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 6 Turning the tide in medicines management: Pharmacist at Arua Regional Referral Hospital talks about how their work has changed Regional pharmacist Harriet Akello of Arua Regional Hospital in her well managed store. In 2011, Harriet Akello chose to leave her private sector job to take up the pharmacist position at Arua Regional Referral Hospital because she saw it as an opportunity to serve a much wider community. She was immediately faced, however, with the many challenges of working in a public hospital with limited resources. Instead of the two pharmacists and four dispensers that Arua Regional Referral Hospital is supposed to have, Harriet works with only two dispensers. The team puts in extra hours of work to meet patient needs and keep the systems running. Medicines management systems were imperfect. Quantification and ordering for essential medicines and health supplies was largely done irrationally, leading to regular stock outs and expiries. Everything from record keeping to preparing routine reports had to be done manually, she said. The area outside the pharmacy was always congested; patients stayed in the queue for hours to get medicines, yet sometimes ended up with nothing or less than what they required. The situation was not any better in the lower-level health facilities in the eight districts served by the hospital. There are 3.5 million people in need of my services, she said. Harriet and her team s duties include planning for the pharmacy department, quantifying pharmaceutical supplies, placing orders with the National Medical Stores, maintaining appropriate storage conditions, tracking the stock levels of the hospital s large inventory of supplies, and ensuring appropriate distribution to all hospital wards and dispensing units. She also provides regular reports to the Ministry of Health and carries out peer supportive supervision of other pharmacists and health workers who manage medicines in the hospital and the region. Harriet and her colleagues can now do their work much more efficiently and serve their patients better, thanks to support from the U.S Agency for International Development (USAID) through the Uganda Health Supply Chain (UHSC) program. UHSC is working in 79 districts to improve facility stores, computerize inventory management systems and upgrade staff knowledge and skills in medicines management. Arua Regional Referral Hospital now has ample space to properly organize supplies after receiving eight high quality shelves for their store. With training, new computer hardware and RxSolution electronic inventory management software, they are able to track stock levels, expiry dates and consumption of pharmaceutical supplies efficiently on their computers and can now generate information for ordering and reporting in minutes. We place our orders with the National Medical Stores two weeks earlier than the deadline date because the required information is available, she said. Although the situation at Arua Regional Referral Hospital is not perfect, Harriet is glad that it is not where it used to be. Do we still experience drug stock outs and late deliveries? Yes, occasionally. Do patients sometimes go away without medicine? Yes. What is important is that we are not the cause of the problem. We are doing our best. When people get the medicines they need, they are happy, and that makes me happy, she says. Moving to evidence-based decision making By Belinda Blick Belinda Blick, M & E Advisor at Pharmacy Department presenting on the facility stock status situation for Essential Medicines and Health Supplies 1. For those of us dealing with pharmaceutical sector data, one of our main issues is that many managers and program staff are not aware of the useful information they have at their fingertips. Or they know, but they don t use the information to enhance their work, says Belinda Blick, M&E Advisor at the Pharmacy Department. Decisions should be based on the evidence wherever possible, particularly when related to the supply of medicines and pharmaceutical services as they have important consequences for patients. Establishing a common understanding of the data available and how the information can be used to identify issues is the aim of the quarterly monitoring and evaluation health commodity meetings that the Pharmacy Department started in January, 2016.
7 ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 7 These meetings, the first of their kind, provide an important opportunity for people with different roles and responsibilities in supply chain management to review current data and trends, identify problems and discuss ways to address the issues and improve system performance. All the participants have some role in managing health commodity logistics data: program M&E specialists, logistics management specialists, central warehouse managers, regional pharmacists and district biostatisticians. Interest in the meetings rapidly grew and now the head of District Health Officers and Chief Administrative Officers are among the more than 60 regular participants. In the meetings, data from routine reports on the stock status of tracer medicines and health supplies and other supply chain performance indicators are presented, including the monthly HMIS 105 facility reports, SPARS supervision reports and the web-based ARV ordering system (WAOS). The data are broken down by program area (TB, HIV, family planning etc.), level of care, district and region. Results from special studies and information about new reporting tools and procedures that are relevant to the group are also shared. Following review of the data, participants break into groups to further discuss specific issues identified and develop activity plans to address problems in their work place whether it be a warehouse, program or district. Their experiences are then shared in the subsequent meeting. The head of District Health Officers, Dr. Ssesimba Badru, values these meetings because they are not just sharing information but building skills in using the available data, tools and resources. District health officers and biostatisticians are now better able to target their efforts and solve problems of medicines management in the districts. Does the quality of supervision impact medicine management improvement in health facilities? By Rachael Henry SPARS has proved to be very effective in improving medicines management in all health facilities. Although we have seen an average 65 percent improvement after five supervisory visits by a medicine management supervisor (MMS), the pace and degree of improvement varies considerably. Upon further examination of the facility data, it looked like some MMS were more effective than other MMS in having facilities improve. To explore this further, Uganda Health Supply Chain (UHSC) carried out a study to see how well supportive supervision is implemented by the MMS and explore the relationship between supportive supervision and quality improvement in facility SPARS score. Studies in other countries have highlighted the importance of supervisors applying supportive supervision rather than more traditional "police-like" supervision to improve service delivery. Supportive supervision involve the health workers in joint problem solving and open discussions, and are part of the team rather than an outside supervisor. The supervisor should provide training and constructive feedback and set targets to empower the supervisees to improve their standard of work. The supervisees should feel they have a valued voice that shapes decisions. In the study, 10 MMS were observed by trained researchers during a routine facility supervisory visit and their performance scored on eleven behaviors and skill categories critical for effective supportive supervision. We found that the MMS implemented supportive supervision poorly, with an average total score of only 40% (out of 100%). They were best in communication with a score of 54% and worst in continuing what had been discussed and agreed on the last visit. There was a striking difference between individual MMS. The highest individual MMS score was 77% and the lowest was 9%. The study also found that there was a ration between how well an MMS practices supportive supervision and how much the facility improved their medicines management or SPARS score at each visit. The better supportive supervision the better impact the SPARS visits would have. On the background of this study it was decided to develop a training course in supportive supervision for all MMS. The course was developed in collaboration with UHSC, Makerere University Department of Pharmacy and Harvard University. By the end of December 2016 all MMS should have been trained. Reference: Henry, R., Nantongo, L., Wagner, K.A., Embrey, M., Trap, B. (in press) Competency in supportive supervision: A study of public sector medicines management supervisors in Uganda. Journal of Pharmaceutical Policy and Practice. To access this article please send an to Sheila Mwebaze, smwebaze@uhsc.ug
8 Introducing Implanon NXT ISSUE 7, MARCH 2017 MINISTRY OF HEALTH PHARMACY DIVISION NEWSLETTER 8 By Dennis Buwembo Most family planning providers are familiar with the onerod three-year Implanon implant, a long-acting reversible contraception method. The manufacturer, Merck & Co, is replacing Implanon classic with Implanon NXT. Implanon NXT is a single-rod subdermal progestagen-only contraceptive (contains etonogestrel 68mg) implant that is inserted just under the skin of a woman's upper arm. It is different from Implanon classic in that it has a pre-loaded non-reusable applicator operable with one hand to help facilitate correct subdermal insertion. It is also radiopaque for identification on X-ray which will aid removal. Planning is underway at the Ministry of Health to enable a smooth transition to Implanon NXT effective in January, Implanon NXT will be phased in over a 6-9 month period to ensure that existing viable Implanon classic stocks are used up to avoid wastage and adequate time is given to training of health workers on the new product. Procurement agencies will synchronise procurement and delivery of Implanon NXT and supplies needed for health worker training (placebos and arm models). A Ministry of Health task team has conducted a rapid assessment of Implanon stock available at national and heath facility levels and is collaborating with implementing partners to map out consumption trends and the numbers of health workers already trained in implant insertion and removal. This information will guide the selection of geographical regions where the transition will be prioritized. District medicines management supervisors will be instrumental in monitoring the implementation of the plan and health facility stock levels throughout the transition period. The Pharmacy Division acknowledges support from District Health and Administrative Officers Health Laboratories, National Malaria Control Euro Health Group Programme and Reproductive Health programme) Implementing partners National Drug Authority Joint Medical Store Imperial Health Sciences Makerere University Uganda Medicines and Therapeutic Advisory Management Sciences for Health Committee Ministry of Health Resource Centre and Technical US Agency for International Development programs (AIDS Control Programme, National US Centre for Disease Control Tuberculosis and Leprosy programme, Central Public US President s Emergency Plan for AIDS Relief (PEPFAR) Ministry of Health Plot 6 Lourdel Road, Wandegeya P. O. Box 7272, Kampala, Uganda Tel: info@health.go.ug Website: Management Sciences for Health Plot 15, Princess Anne, Bugolobi P. O. Box 71419, Kampala, Uganda Tel: uhsc@uhsc.ug Website: This newsletter is made possible by the generous support of the American people through the President s Emergency Plan for AIDS Relief (PEPFAR) and the US Agency for International Development (USAID), under the terms of Cooperative Agreement number AID-617-A The contents are the responsibility of Management Sciences for Health and do not necessarily reflect the views of USAID or the US government.
FEDERAL MINISTRY OF HEALTH
FEDERAL MINISTRY OF HEALTH DEPARTMENT OF PUBLIC HEALTH NATIONAL TUBERCULOSIS, LEPROSY AND BURULI ULCER CONTROL PROGRAME. THE NEW ANTI-TB DRUG FORMULATIONS FOR CHILDREN: STRATEGIES FOR ROLL-OUT IN NIGERIA
More informationStrategy of TB laboratories for TB Control Program in Developing Countries
Strategy of TB laboratories for TB Control Program in Developing Countries Borann SAR, MD, PhD, Institut Pasteur du Cambodge Phnom Penh, Cambodia TB Control Program Structure of TB Control Establish the
More informationImproving availability of human resources for health, essential medicines and supplies by district leaders using QI methods:
U G A N D A C H A N G E PA C K A G E Improving availability of human resources for health, essential medicines and supplies by district leaders using QI methods: Tested changes implemented in six districts
More informationStandard operating procedures: Health facility malaria committees
The MalariaCare Toolkit Tools for maintaining high-quality malaria case management services Standard operating procedures: Health facility malaria committees Download all the MalariaCare Tools from: www.malariacare.org/resources/toolkit
More informationNational Performance Report on Medicines Management. The fourth National Performance Report on medicines management is here.
This report covers the period from: Issue no. 4 January 2015 through March 2015 Tuesday, April 21, 2015 Published by: Data source: MMS data version 4.0 P.O. Box 7272 Executive Summary National Performance
More informationPolicy Guidelines and Service Delivery Standards for Community Based Provision of Injectable Contraception in Uganda
Policy and Service Delivery Standards for Community Based Provision of Injectable Contraception in Uganda Addendum to Uganda National Policy and Service Standards for Sexual and Reproductive Health December
More informationAnnual Pharmaceutical Sector Performance Report
Ministry of Health Republic of Uganda Annual Pharmaceutical Sector Performance Report 2014-2015 June 2016 FOREWORD The Annual Pharmaceutical Sector Performance Report provides us with a valuable picture
More informationRWANDA S COMMUNITY HEALTH WORKER PROGRAM r
RWANDA S COMMUNITY HEALTH WORKER PROGRAM r Summary Background The Rwanda CHW Program was established in 1995, aiming at increasing uptake of essential maternal and child clinical services through education
More informationIntroduction to the Infection Control Assessment Tool (ICAT)
Introduction to the Infection Control Assessment Tool (ICAT) Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green
More informationTowards Quality Care for Patients. Fast Track to Quality The Six Most Critical Areas for Patient-Centered Care
Towards Quality Care for Patients Fast Track to Quality The Six Most Critical Areas for Patient-Centered Care National Department of Health 2011 National Core Standards for Health Establishments in South
More informationGrant Aid Projects/Standard Indicator Reference (Health)
Examples of Setting Indicators for Each Development Strategic Objective Grant Aid Projects/Standard Indicator Reference (Health) Sector Development strategic objectives (*) Mid-term objectives Sub-targets
More informationBuilding Pharmaceutical Management Capacity in South Sudan
Building Pharmaceutical Management Capacity in South Sudan January 2017 BACKGROUND South Sudan s health system is struggling to overcome a myriad of challenges, including poor pharmaceutical supply management
More informationMicrobicides Readiness Assessment Tool A tool for diagnosing and planning for the introduction of microbicides in public-sector health facilities
Microbicides Readiness Assessment Tool A tool for diagnosing and planning for the introduction of microbicides in public-sector health facilities BACKGROUND This tool is intended to help evaluate the extent
More informationReducing Harm and Healthcare Costs: A Review Of A Physician's Unlimited License To Practice
Reducing Harm and Healthcare Costs: A Review Of A Physician's Unlimited License To Practice Generally, physicians are licensed under what is termed an "unlimited" license. Underlying the intent of unlimited
More informationFEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017
FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME EPIDEMIOLOGICAL ANALYSIS OF TUBERCULOSIS BURDEN AT NATIONAL AND SUB NATIONAL LEVEL (EPI ANALYSIS SURVEY) TERMS OF REFERENCE
More informationNATIONAL MEDICINES POLICy 2015 THE REPUBLIC OF UGANDA MINISTRY OF HEALTH
NATIONAL MEDICINES POLICy 2015 THE REPUBLIC OF UGANDA MINISTRY OF HEALTH National Medicines Policy july 2015 A THE REPUBLIC OF UGANDA MINISTRY OF HEALTH National Medicines Policy july 2015 I Published
More informationHow a Leakage Study can teach how effectively aid is transformed into Services
Office of the Auditor General of Norway How a Leakage Study can teach how effectively aid is transformed into Services Sivertsen, Birgitte Frogner 25 September 2013 Introduction This paper is based on
More informationCONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION
CONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION November 2016 ABOUT CORD The Canadian Organization for Rare Disorders (CORD) provides a strong common voice to advocate for health policy and a healthcare
More informationSudan Ministry of Health Capacity Development Plan
Sudan Ministry of Health Capacity Development Plan Progress Report: January June 2016 1 Photograph Hassan Bablonia Contents Background 2 Partnership between FMOH and UNDP 3 CD Plan Implementation Arrangements
More informationStrategies to Improve the Use of Medicines Standard Treatment Guidelines
Strategies to Improve the Use of Medicines Standard Treatment Guidelines Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control
More informationLegislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018
Legislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018 Dr. Rania Bader, HRH2030 Health Workforce Competency Lead HRH2030 The Human Resources for Health (HRH2030) is a
More informationIntroducing New TB Medicines and Regimens: Is Success Driven by Systems? Chinwe Owunna Antonia Kwiecien Dumebi Mordi
Introducing New TB Medicines and Regimens: Is Success Driven by Systems? Chinwe Owunna Antonia Kwiecien Dumebi Mordi Objectives Review key points on the global threat of drug resistant-tb Explore the importance
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationImproved Maternal, Newborn and Women s Health through Increased Access to Evidence-based Interventions. Source:DHS 2003
KENYA Improved Maternal, Newborn and Women s Health through Increased Access to Evidence-based Interventions INTRODUCTION Although Kenya is seen as an example among African countries of rapid progress
More informationSustainable Financing to Ensure Access for All to TB Medicines
Sustainable Financing to Ensure Access for All to TB Medicines David Collins MSH GLOBAL TB CONFERENCE 2015, BANGKOK THAILAND Purpose of the Session What financing challenges exist that restrict access
More informationWHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis
WHO/HTM/TB/2005.354 Task analysis The basis for development of training in management of tuberculosis This document has been prepared in conjunction with the WHO training courses titled Management of tuberculosis:
More informationSupply Chain and Pharmaceutical System
MTCT Plus Durban site logistics baseline assessment Supply Chain and Pharmaceutical System Program at Assessment PHARMACY STAFF The plan to hire a part time pharmacy assistant has been set aside for now
More informationApril 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org April 17, 2013 Paul vanostenberg, DDS, MS Vice President Accreditation and Standards
More informationINTEGRATED CHRONIC DISEASE MANAGEMENT
INTEGRATED CHRONIC DISEASE MANAGEMENT INTEGRATED CHRONIC DISEASE MANAGEMENT Integrated Chronic Disease Management (ICDM) is a model of managed care that provides for integrated prevention, treatment and
More informationCEOCFO Magazine. Andy Reeves, RPh Chief Executive Officer OptiMed Specialty Pharmacy
CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: October 30, 2017 Q&A with Andy Reeves, RPh, CEO of OptiMed Specialty Pharmacy, a National Specialty and Infusion Pharmacy dedicated to Managing
More informationEngaging the Private Retail Pharmaceutical Sector in TB Case Finding in Tanzania: Pilot Dissemination Meeting Report
Engaging the Private Retail Pharmaceutical Sector in TB Case Finding in Tanzania: Pilot Dissemination Meeting Report February 2014 Engaging the Private Retail Pharmaceutical Sector in TB Case Finding
More informationChanging Malaria Treatment Policy to Artemisinin-Based Combinations
Changing Malaria Treatment Policy to Artemisinin-Based Combinations An Implementation Guide Developed by the Rational Pharmaceutical Management Plus Program in collaboration with the Roll Back Malaria
More informationExperiences from Uganda
Engaging patients family and community for safer and higher quality care Experiences from Uganda Global patient safety ministerial summit WHO, 29-30 March 2017, Bonn, Germany Regina M.N. Kamoga Executive
More informationCHRO N I C DIS EAS ES A HEALTH SYSTEMS APPROACH TO CHRONIC DISEASES. Stronger health systems. Greater health impact.
CHRO N I C DIS EAS ES A HEALTH SYSTEMS APPROACH TO CHRONIC DISEASES Stronger health systems. Greater health impact. CERVICAL CANCER SCREENING IN UGANDA Cervical cancer is one of the common life-threatening,
More informationSupporting drug and therapeutics committees in Sierra Leone to promote safe, appropriate medicine use
Supporting drug and therapeutics committees in Sierra Leone to promote safe, appropriate medicine use October 2017 Irrational medicine use and poor pharmaceutical management at all levels are widespread
More informationMrs SS Mazibuko Manager: Pharmaceutical Services Health Systems Trust Conference 05 May 2016
Improving access to chronic medication using the Central Chronic Medicine Dispensing and Distribution (CCMDD) delivery model at healthcare facilities in Umzinyathi District Mrs SS Mazibuko Manager: Pharmaceutical
More informationA people-centred model of TB care
A people-centred model of TB care 7th TB Symposium Ministry of Health of the Kyrgyz Republic and Médecins Sans Frontières, March 1, 2018 Dr Martin van den Boom, MD, MSc PH, Technical Officer, Joint TB,
More informationPROGRAM BRIEF UGANDA. Integrated Case Management of Pneumonia, Diarrhea & Malaria through the Five & Alive Franchise Network
PROGRAM BRIEF UGANDA Integrated Case Management of Pneumonia, Diarrhea & Malaria through the Five & Alive Franchise Network I ntegrated case management (ICM) is a strategy to reduce child morbidity and
More informationStrengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India
Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India Dr K S Sachdeva Additional Deputy Director General Central TB Division Ministry of Health & Family Welfare Government of
More informationUSAID s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program ( )
USAID s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program (2011-2016) IR* 1: Pharmaceutical sector governance strengthened 1.1 Good governance principles embodied across all health
More informationREPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria
REPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria Overview of Clinical Laboratories The duties of clinical laboratories
More informationFAST. A Tuberculosis Infection Control Strategy. cough
FAST A Tuberculosis Infection Control Strategy FIRST EDITION: MARCH 2013 This handbook is made possible by the support of the American people through the United States Agency for International Development
More informationSenior Research, Measurement and Evaluation Officer (based in Abuja) Project: SIFPO/LEAP Project
SOCIETY FOR FAMILY HEALTH EXCITING JOB VACANCIES Society for Family Health (SFH) is one of the leading public health non-governmental organizations (NGOs) in Nigeria, implementing programmes in Reproductive
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationManagement of patients with TB/HIV Gunta Kirvelaite
Management of patients with TB/HIV Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department. MDR TB physician. WHO Collaborating Centre for
More informationMedicines New Zealand
Implementing Medicines New Zealand 2015 to 2020 Medicines New Zealand Access Quality Optimal use Released 2015 health.govt.nz Citation: Ministry of Health. 2015. Implementing Medicines New Zealand 2015
More informationJuba Teaching Hospital, South Sudan Health Systems Strengthening Project
Juba Teaching Hospital, South Sudan Health Systems Strengthening Project Date: Prepared by: May 26, 2017 Dr. Taban Martin Vitale and Richard Anyama I. Demographic Information 1. City & State: Juba, Central
More informationImproving Malaria Case Management in Ghana
GHANA December, 2016 Edition Message from the Programme Manager, NMCP Improving Malaria Case Management in Ghana Maintaining Healthcare Workers' Skills and Knowledge through Quality Assurance Processes
More informationMeasurement of TB Indicators using e-tb Manager (TB Patient Management Information System)
Measurement of TB Indicators using e-tb Manager (TB Patient Management Information System) July 2017 Measurement of TB Indicators using e-tb Manager (TB Patient Management Information System) Md. Abu Taleb
More informationFinancial impact of TB illness
Summary report Costs faced by (multidrug resistant) tuberculosis patients during diagnosis and treatment: report from a pilot study in Ethiopia, Indonesia and Kazakhstan Edine W. Tiemersma 1, David Collins
More informationDirectly Observed Therapy for Active TB Disease and Latent TB Infection
Directly Observed Therapy for Active TB Disease and Latent TB Infection Policy Number TB-5001 Effective Date (original issue) September 6, 1995 Revision Date (most recent) June 26, 2008 Subject Matter
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL SECTION 21 APPLICATION FORM Only to be used for orthodox/allopathic medicines for human use. 1. Fax completed form (i.e. pages 1-10), proof of payment of application fee (if applicable)
More informationCollaboration of WHO with the Regions and Countries
Collaboration of WHO with the Regions and Countries Dr Cécile Macé Essential Medicines and Health Products Department Technical Briefing Seminar on Pharmaceutical Policies, Nov 2015 1 English TBS Nov 2015
More informationUganda National Association of Private Hospitals (UNAPH)
Uganda National Association of Private Hospitals (UNAPH) Private Hospital Review, 2011 (PFP Private Health Subsector) The majority of diseases especially malaria and HIV/AIDS episodes in Uganda are initially
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINES FOR RECALL/ WITHDRAWAL OF MEDICINES This document has been prepared to serve as a recommendation to applicants regarding the recalls of medicines, and the Medicines
More informationCharting for Midwives. Getting Credit For the Work You Do
Charting for Midwives Getting Credit For the Work You Do Moving Beyond S.O.A.P. The U.S. health care system is moving past fee-for-service billing. In the future, the providers will be reimbursed based
More informationCitizen s Engagement in Health Service Provision in Kenya
Citizen s Engagement in Health Service Provision in Kenya Hon. (Prof) Peter Anyang Nyong o, EGH, MP Minister for Medical Services, Kenya Abstract Kenya s form of governance has moved gradually from centralized
More informationWeb-Based ARV Ordering and Reporting System (WAOS) Report
Web-Based ARV Ordering and Reporting System (WAOS) Report April 2017 May 2017 Uganda Ministry of Health STD/AIDS Control Programme P.O. Box 7272 Kampala Uganda Phone: +256-414-4257409 Contact:pachii@msh.org
More informationGOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION. National Infection Prevention and Control Policy
GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION National Infection Prevention and Control Policy Page 1 of 24 Contents 1 Introduction... 8 1.1 Background... 8 1.2 Healthcare-Associated
More informationValue Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access
Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access 09 June 2016 Pr. Mondher Toumi M.D., MSc., Ph.D. Professor in Public Health Department Research Unit EA 3279, Aix-Marseille University
More informationUNHCR Standardized Health Information System (HIS) Health Information System (HIS) Slide 1
UNHCR Standardized Health Information System (HIS) 2006 Slide 1 Objectives of HIS 1. Rapidly detect and respond to health problems and epidemics 2. Monitor trends in health status and continually address
More informationSaving Every Woman, Every Newborn and Every Child
Saving Every Woman, Every Newborn and Every Child World Vision s role World Vision is a global Christian relief, development and advocacy organization dedicated to improving the health, education and protection
More informationMEASURE DHS SERVICE PROVISION ASSESSMENT SURVEY HEALTH WORKER INTERVIEW
06/01/01 MEASURE DHS SERVICE PROVISION ASSESSMENT SURVEY HEALTH WORKER INTERVIEW Facility Number: Interviewer Code: Provider SERIAL Number: [FROM STAFF LISTING FORM] Provider Sex: (1=MALE; =FEMALE) Provider
More informationTowards Quality Care for Patients. National Core Standards for Health Establishments in South Africa Abridged version
Towards Quality Care for Patients National Core Standards for Health Establishments in South Africa Abridged version National Department of Health 2011 National Core Standards for Health Establishments
More informationInternational Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services
International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part
More informationIMCI at the Referral Level: Hospital IMCI
Integrated Management of Childhood Illness (IMCI) Implementation in the Western Pacific Region IMCI at the Referral Level: Hospital IMCI 6 IMCI at the Referral Level: Hospital IMCI Hospital referral care:
More informationPharmacy Operations. General Prescription Duties. Pharmacy Technician Training Systems Passassured, LLC
Pharmacy Operations General Prescription Duties Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, General Prescription Duties PassAssured's Pharmacy Technician Training Program
More informationExecutive summary. 1. Background and organization of the meeting
Regional consultation meeting to support country implementation of the top ten indicators to monitor the End TB Strategy, collaborative TB/HIV activities and programmatic management of latent TB infection
More informationJOB DESCRIPTION. Job Title: Nutrition Officer Location: Warrap. Travel involved: As required Child safeguarding level: TBC
JOB DESCRIPTION Job Title: Nutrition Officer Location: Warrap Department: Programs Length of contract: Role type: National Grade 6 Travel involved: As required Child safeguarding level: TBC Reporting to:
More informationDyah Erti Mustikawati
SCALING UP PPM IN INDONESIA Seventh Meeting of the Subgroup on Public-Private Mix for TB Care and Control 23-24 October 2011, Lille, France Dyah Erti Mustikawati NTP Manager MOH Indonesia Content Background
More informationFEDERAL MINISTRY OF HEALTH DEPARTMENT OF PUBLIC HEALTH. National Tuberculosis and Leprosy Control Programme. A Tuberculosis Infection Control Strategy
FEDERAL MINISTRY OF HEALTH DEPARTMENT OF PUBLIC HEALTH National Tuberculosis and Leprosy Control Programme FAST A Tuberculosis Infection Control Strategy 1 Acknowledgements This FAST Guide is developed
More informationMMV Access Symposium Getting Antimalarials to Patients Kampala, Uganda. Accredited Drug Dispensing Outlets: Tanzania Experience
MMV Access Symposium Getting Antimalarials to Patients Kampala, Uganda Accredited Drug Dispensing Outlets: Tanzania Experience Dr. Sikubwabo S. Ngendabanka Director, Business Support - TFDA 9 May 2007
More informationAffordable Medicines Facility - malaria
Affordable Medicines Facility - malaria Antimalarial Treatment Strategies Conference 31 March 3 April 2008 History of the Affordable Medicines Facility malaria project 2004 2007 2008 RBM leads a Partnership
More informationA fresh start for registration. Improving how we register providers of all health and adult social care services
A fresh start for registration Improving how we register providers of all health and adult social care services The Care Quality Commission is the independent regulator of health and adult social care
More informationLaw on Medical Devices
Law on Medical Devices The Law is published in the Official Gazette of the Republic of Montenegro, no. 79/2004 on 23.12.2004. I GENERAL PROVISIONS Article 1 Manufacturing and distribution of medical devices
More informationStrengthening Namibia s Pharmacy Sector and Workforce
SIAPS TECHNICAL BRIEF Strengthening Namibia s Pharmacy Sector and Workforce The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program works to ensure access to quality pharmaceutical
More informationEpidemiological review of TB disease in Sierra Leone
Epidemiological review of TB disease in Sierra Leone October 2015 Laura Anderson WHO (Switzerland) Esther Hamblion WHO (Liberia) Contents 1. INTRODUCTION 4 2. PURPOSE 5 2.1 OBJECTIVES 5 2.2 PROPOSED OUTCOMES
More informationThe registration department at Kuwait Drug and Food Control Administration (KDFCA) monitors and
Appendix 1 Background on some of the pharmaceutical sectors in Kuwait Registration The registration department at Kuwait Drug and Food Control Administration (KDFCA) monitors and supervises all pharmaceuticals,
More informationNewsletter. The Integrated Health Systems Strengthening Project (IHSSP) April-July Volume 1. Issue 1
April-July 2013 Volume 1 Issue 1 The Integrated Health Systems Strengthening Project (IHSSP) Newsletter Photo: Todd Shapera The Integrated Health Systems Strengthening Project (IHSSP) IHSSP Office in Rwanda
More informationBMC Partners Meeting. Ghana BMC project Progress Geneva 22 November, 2011
BMC Partners Meeting Ghana BMC project Progress Geneva 22 November, 2011 Introduction The Better Medicines for Children (BMC) Project funded by the Bill and Melinda Gates Foundation aims to improve access
More informationThe Health Sector Transformation Plan (HSTP) Federal Democratic Republic of Ethiopia, Ministry of Health
The Health Sector Transformation Plan (HSTP) Federal Democratic Republic of Ethiopia, Ministry of Health Strategic themes of HSTP Key words (HSTP) Quality and equity Universal health coverage Transformation
More informationAn effective tool to manage the distribution of medicines and monitor the treatment in hospital pharmacies
An effective tool to manage the distribution of medicines and monitor the treatment in Gianpaolo Franzoso 1 1. Ospedale civile S. Maria Regina degli Angeli. Adria (RO) Italy Abstract Introduction: The
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationRequest for proposals (RFP) For. Operational Research on Tuberculosis. in support of. Challenge TB Project in Tanzania. Issuance Date: 30/1/2018
Request for proposals (RFP) For Operational Research on Tuberculosis in support of Challenge TB Project in Tanzania Issuance Date: 30/1/2018 Submit Expressions of Interest & questions to: pamela.kisoka@kncvtbc.org
More informationTERMS OF REFERENCE: PRIMARY HEALTH CARE
TERMS OF REFERENCE: PRIMARY HEALTH CARE A. BACKGROUND Health Status. The health status of the approximately 21 million Citizens of Country Y is among the worst in the world. The infant mortality rate is
More informationStrategies to Improve Medicine Use Drug and Therapeutics Committees
Strategies to Improve Medicine Use Drug and Therapeutics Committees Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry
More informationRFP Informational Session: Pediatric DTG. November 10, 2017
RFP Informational Session: Pediatric DTG November 10, 2017 The Optimal ARV project aims to generate demand for target ARVs in high-burden focal countries, driving rapid uptake and lowering global costs
More informationProgress in the rational use of medicines
SIXTIETH WORLD HEALTH ASSEMBLY A60/24 Provisional agenda item 12.17 22 March 2007 Progress in the rational use of medicines Report by the Secretariat 1. The present report provides a summary of the major
More informationPost Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015
Post Market Surveillance Requirements SAMED Regulatory Conference 2 December 2015 Topics Surveillance & Vigilance Adverse Events Reportable Adverse Events Reporting Adverse Events Time frames Exemptions
More informationNational Health Insurance. Sham Moodley BSc(UCD-Ire),BPharm(UKZN),PDM(HIV/AIDS),MPhil(HIV/AIDS)(SU) F
+ National Health Insurance Sham Moodley BSc(UCD-Ire),BPharm(UKZN),PDM(HIV/AIDS),MPhil(HIV/AIDS)(SU) 0824504472 031 4613700 031 4687610 031 4612702 F + Perception + International and local imperatives
More informationAPPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION
APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION This joint statement was developed by the CMA and the Canadian Pharmaceutical
More informationHealth System Strengthening for Developing Countries
Health System Strengthening for Developing Countries Bob Emrey Health Systems Division USAID Bureau for Global Health 2009 Humanitarian Logistics Conference Georgia Tech Atlanta, Georgia February 19, 2009
More informationOBQI for Improvement in Pain Interfering with Activity
CASE SUMMARY OBQI for Improvement in Pain Interfering with Activity Following is the story of one home health agency that used the outcome-based quality improvement (OBQI) process to enhance outcomes for
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationAUDIT UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA. Report No Issue Date: 15 January 2014
UNITED NATIONS DEVELOPMENT PROGRAMME AUDIT OF UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA Report No. 1130 Issue Date: 15 January 2014 Table of Contents
More informationUS Compounding 2515 College Ave Conway, AR (800)
PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy
More informationFERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014
FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014 1.0.0 DOMAIN 1 - FOUNDATIONAL KNOWLEDGE 1.1.0 Learner (Learner) Apply knowledge from the foundational sciences (i.e., pharmaceutical,
More informationPosition Statement on Prescription Drug Shortages in Canada
CMA POLICY Position Statement on Prescription Drug Shortages in Canada The escalation in shortages of prescription drugs in the past few years and the ongoing disruptions to supply experienced in Canada
More informationStandard operating procedures for the conduct of outreach training and supportive supervision
The MalariaCare Toolkit Tools for maintaining high-quality malaria case management services Standard operating procedures for the conduct of outreach training and supportive supervision Download all the
More informationPharmacy Technician Structured Practical Training Program
Pharmacy Technician Structured Practical Training Program Logbook Updated August 2016 *To be reviewed by Supervisor and Pharmacy Technician-in-Training and used in conjunction with the Pharmacy Technician
More information